Indegene and Microsoft Join Forces to Revolutionize Life Sciences with Generative AI

Healthcare tech firm Indegene has partnered with Microsoft to enhance the adoption of Generative AI (GenAI) services within the global life sciences sector. The collaboration aims to innovate and streamline business processes across various functions using GenAI technology, with nearly 50 use cases in advanced pilot stages.

Healthcare tech firm Indegene announced a strategic partnership with Microsoft on Thursday to boost the adoption of Generative AI (GenAI) services in the global life sciences industry. This alliance aims to drive faster and more efficient innovation.

The two companies plan to develop comprehensive resources in medical and technology tools, focusing on co-innovating GenAI services and workflows across commercial, medical, regulatory, and clinical sectors. 'GenAI offers a once-in-a-decade chance for life sciences firms to modernize operations and significantly enhance efficiency,' said Indegene CTO Tarun Mathur. He added that nearly 50 real-world business problems are being addressed through advanced pilot stages using GenAI.

Microsoft India & South Asia COO Alok Lall emphasized the transformative impact of Generative AI on various industries, including life sciences. 'Combining Indegene's expertise with Microsoft Azure OpenAI Service and Microsoft Copilot positions us at the cutting edge of advancing generative AI in life sciences,' Lall stated. The partnership will enable life sciences companies to fully leverage AI's potential, driving innovation and scalability within the sector.